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The IcsA autotransporter protein is a major virulence factor of the human intracellular 30 
pathogen Shigella flexneri. IcsA is polarly distributed in the outer membrane of S. flexneri 31 
and interacts with components of the host actin-polymerization machinery to facilitate 32 
intracellular actin-based motility and subsequent cell-to-cell spreading of the bacterium. We 33 
sought to characterize the biochemical properties of IcsA in the bacterial outer membrane. 34 
Chemical cross-linking data suggested that IcsA exists in a complex in the outer membrane. 35 
Furthermore, reciprocal co-immunoprecipitation of differentially epitope-tagged IcsA 36 
proteins indicated that IcsA is able to self-associate. The identification of IcsA linker-37 
insertion mutants that were negatively dominant provided genetic evidence of IcsA-IcsA 38 
interactions. From these results, we propose a model whereby IcsA self-association facilitates 39 





Shigella spp. are highly adapted human pathogens that cause bacillary dysentery and 43 
extensive global morbidity and mortality (Levine et al., 2007). Ingested Shigellae invade 44 
colonic epithelial cells, where they multiply within the host cell cytoplasm and become 45 
motile via the polymerization of host actin in a process termed actin-based motility (ABM) 46 
(Suzuki et al., 1996; 1998; 2002). Motile bacteria are able to infect adjacent cells, enabling 47 
the lateral spread of the focus of infection throughout the epithelium. Actin polymerization is 48 
initiated by the polarly distributed Shigella IcsA (VirG) protein (Bernardini et al., 1989; Lett 49 
et al., 1988), which recruits the host neural Wiskott-Aldrich syndrome protein (N-WASP), a 50 
key regulator of the actin cytoskeleton (Goldberg, 2001; Snapper et al., 2001; Suzuki et al., 51 
1998). N-WASP and other members of the Wiskott-Aldrich syndrome protein (WASP) 52 
family function as a link between signalling pathways and de novo actin polymerization by 53 
recruiting the actin polymerizing complex Arp2/3, initiating actin polymerization-driven host 54 
cell motility and morphological changes (Miki & Takenawa, 2003; Yarar et al., 1999). IcsA 55 
is essential for ABM and thus S. flexneri virulence (Kotloff et al., 1996; 2002; Lett et al., 56 
1988; Makino et al., 1986; Sansonetti et al., 1991). 57 
IcsA is a member of the autotransporter (AT) family of proteins, which is the largest 58 
family of extracellular proteins in Gram-negative bacteria (Pallen et al., 2003). A prototypical 59 
AT protein consists of an N-terminal signal sequence that facilitates export across the inner-60 
membrane; an internal passenger domain that exerts the effector function; and a C-terminal 61 
translocation domain required to direct export of the protein across the outer-membrane (OM) 62 
via the Bam complex, and to form a β-barrel OM anchor for the extracellular passenger 63 
domain (Henderson et al., 2004; Jain & Goldberg, 2007; Peterson et al., 2010).  64 
A distinct sub-family of ATs has been shown to be trimeric and IcsA is related to a 65 
subgroup of self associating ATs (SAATs) that mediate bacterial aggregation and biofilm 66 
formation (Cotter et al., 2005; Klemm et al., 2006; Meng et al., 2011). Emerging evidence 67 
suggests that a subset of conventional ATs are capable of oligomerisation in the OM. In these 68 
proteins, oligomerization is facilitated either through interactions between adjacent effector 69 
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domains (Gangwer et al., 2007; Swanson et al., 2009; Xicohtencatl-Cortes et al., 2010), or 70 
translocation domains (Marín et al., 2010; Müller et al., 2005; Veiga et al., 2002). How 71 
broadly applicable oligomerisation might be within the large AT family of proteins remains 72 
to be determined. Indeed, some ATs have specifically been shown to exist as monomers 73 
(Hritonenko et al., 2006; Marín et al., 2010), and crystal structures of translocation domains 74 
obtained from EspP and NalP suggest a monomeric existence (Barnard et al., 2007; Oomen et 75 
al., 2004). The biological significance of AT oligomerization remains unclear. IcsA has not 76 
been previously investigated in this regard. 77 
The aim of our study was to investigate the state of IcsA in the OM environment, 78 
which is fundamental to understanding the interaction of IcsA with host proteins such as N-79 
WASP, and to S. flexneri virulence. In this study, we have shown that IcsA is present within a 80 
complex in the OM, and detected the existence of direct IcsA-IcsA interactions within this 81 
complex. The identification of negative-dominant IcsA mutants that influenced S. flexneri 82 
plaque formation, and hence intercellular spreading, provided genetic evidence of direct 83 
IcsA-IcsA interaction, and demonstrated the functional relevance of IcsA self-association.  84 
 85 
METHODS 86 
Bacterial strains and Plasmids. The strains and plasmids used in this study are listed in 87 
Table 1.  88 
Growth media and growth conditions. S. flexneri strains were grown from a Congo-Red-89 
positive colony as previously described (Morona et al., 2003). All bacterial strains were 90 
routinely cultured in Luria Bertani (LB) media. Bacteria were grown in media with 91 
antibiotics for 16 h with aeration then sub-cultured 1:50 and grown to mid exponential-phase 92 
by incubation with aeration for 2 h at 37°C. Where appropriate, media were supplemented 93 
with ampicillin (100 µg ml-1), chloramphenicol (25 µg ml-1), kanamycin (50 µg ml-1), 94 
tetracycline (50 µg ml-1). Mueller-Hinton broth and agar were used to culture strains in the 95 
presence of trimethoprim (10 µg ml-1).  96 
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DNA methods. Escherichia coli K-12 strain DH5α was used for routine cloning and general 97 
cloning techniques, and PCR and DNA sequencing were performed as described previously 98 
(May & Morona, 2008).  99 
Chemical cross-linking. Cross-linking with dithio-bis(succinimidylpropionate) (DSP; 100 
Pierce) was performed as described previously (Thanabalu et al., 1998). Mid exponential-101 
phase cultures were washed in buffer (120 mM NaCl, 20 mM sodium phosphate pH 7.2) and 102 
DSP was added to each sample at a final concentration of 0.2 mM in the same buffer. 103 
Samples were incubated for 30 min at 37°C. Cross-linking was then quenched with 20 mM 104 
Tris pH 7.5, samples were washed in buffer, resuspended in SDS-PAGE sample buffer 105 
(Lugtenberg et al., 1975) either with or without β-mercaptoethanol. Samples were then 106 
heated to 60°C for 5 min, prior to being resolved by SDS-PAGE. Cross-linking of cells from 107 
strains RMA2205, RMA2208, RMA2209, was performed as above, except that after 108 
quenching, the cells were lysed by passage through a French pressure cell; the lysate was 109 
centrifuged at 100,000×g for 1 h, and the pelleted whole membranes resuspended in SDS-110 
PAGE sample buffer either with or without β-mercaptoethanol. Formaldehyde cross-linking 111 
was performed as described previously (Prossnitz et al., 1988). Mid-exponential phase 112 
bacteria were washed in 10 mM K2HPO4/KH2PO4 buffer and resuspended and formaldehyde 113 
added at a final concentration 0.5% and incubated for 1 h at RT. Samples were then washed 114 
once again as above and resuspended in SDS-PAGE sample buffer. Aliquots of each sample 115 
were heated at either 60°C for 10 min or 100°C for 20 min, prior to SDS-PAGE. 116 
Construction of plasmids 117 
pKMRM252 was constructed by sub-cloning the EcoRI-SalI fragment of pIcsA encoding 118 
IcsAWT into likewise digested pBBR1MCS-2. FLAG and BIO tagged derivatives of IcsA 119 
were constructed as follows. Complementary oligonucleotides (Table 2) encoding either the 120 
FLAG epitope (IcsA-FLAG-F1, IcsA-FLAG-R1; DYKDDDDK) or the BIO sequence (KM1-121 
BIO-F, KM1-BIO-R; GLNDIFEAQKIEWH) were annealed as described previously 122 
(Enninga et al., 2005). The resultant dsDNA possessed NotI compatible 5' overhangs, and 123 
was ligated into the unique NotI site within the linker-insertion of pKMRM1, producing 124 
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plasmids pKMRM250 (encoding icsAi87::FLAG) and pMG55 (encoding icsAi87::BIO). To enable 125 
co-expression with pMG55, the EcoRI-SalI fragment of pKMRM250 encoding icsAi87::FLAG 126 
was sub-cloned between the EcoRI and SalI sites of the compatible plasmid pBBR1MCS-2, 127 
producing plasmid pKMRM270. We confirmed that IcsAi87::FLAG and IcsAi87::BIO were 128 
functionally comparable to IcsAWT by introducing either pKRM250 or pMG55 into 129 
RMA2041 (Table 1) and performing plaque assays (data not shown). 130 
Reciprocal co-purification of FLAG- and BIO-tagged IcsA.  131 
E. coli UT5600 was transformed with pKMRM270 and pMG55, enabling co-expression of 132 
IcsAi87::FLAG and IcsAi87::BIO resulting in in strain MG157. Control strains were also generated 133 
that expressed untagged IcsAi87 [pKMRM1] with either IcsAi87::FLAG [pKRM270] (MG250) 134 
or IcsAi87::BIO [pMG55] (MG251). Strains MG157, MG250, and MG251 additionally carried 135 
pCY216 (Chapman-Smith et al., 1994). 136 
Cultures (5 L) of MG157, MG250, and MG251 were grown 16 h at 30ºC and 137 
extraction of outer membrane proteins from each strain was performed at 4ºC as previously 138 
described (Veiga et al., 2002). Briefly, bacteria were pelleted, resuspended in TN buffer (20 139 
mM Tris-HCl pH 8.0, 10 mM NaCl), lysed by passage in a French pressure cell at 12,000 psi, 140 
and centrifuged at 100,000×g for 1 h. The pellet was solubilised in TN buffer supplemented 141 
with 1.5% (v/v) Triton X-100 (Sigma) for 30 min, and centrifuged at 100,000×g for 1 h. The 142 
resulting pellet was solubilised in TN buffer supplemented with 1% (w/v) Zwittergent 3-14 143 
(Calbiochem) for 30 min, and centrifuged at 100,000×g for 1 h. The supernatant containing 144 
solubilised outer-membrane proteins was collected, and diluted to 0.1% (w/v) Zwittergent 3-145 
14 with TN buffer. Solubilised material was then used in affinity purification using FLAG 146 
M2 resin (Sigma) or MyOne streptavidin T1 Dynabeads (Invitrogen). Samples and beads or 147 
resin were incubated overnight at 4ºC, washed six times for 1.5 h in 8 ml TN buffer 148 
containing 0.1% (w/v) Zwittergent 3-14. Proteins were eluted in SDS-PAGE sample buffer 149 
from FLAG M2 resin; streptavidin-Dynabeads were heated at 100oC for 5 min to release 150 
bound protein, pelleted at 16,000×g for 5 min, and the supernatant then diluted in SDS-PAGE 151 
sample buffer for electrophoresis. 152 
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SDS-PAGE and Western blotting. Samples were separated on 7.5% or 12% SDS-PAGE 153 
gels and transferred to a nitrocellulose membrane.  The membrane was blocked for 1 h in 154 
TTBS (Tris-buffered saline, 0.05% Tween-20) containing 5% skim milk and incubated with 155 
either rabbit anti-IcsA polyclonal antibody (Van Den Bosch et al., 1997), streptavidin-HRP 156 
(Chemicon), or with rabbit anti-FLAG M2 (Sigma) in TTBS overnight. After three 10 min 157 
washes in TTBS the membrane was incubated with horseradish peroxidase (HRP)-conjugated 158 
goat anti-rabbit or a HRP-conjugated goat anti-mouse secondary antibodies (Biomediq DPC) 159 
for 2 h, washed three times in TTBS, then three times in Tris-buffered saline. The membrane 160 
was incubated with Chemiluminescence Substrate (Sigma) for 1 min. Chemiluminescence 161 
was detected by exposure of the membrane to X-ray film (AGFA) and the film was 162 
developed using a Curix 60 automatic X-ray film processor (AGFA).  163 
Plaque assays. Plaque assays were performed with HeLa cells as described previously (May 164 
& Morona, 2008). Briefly, HeLa cells were maintained in MEM, 10% FCS with penicillin 165 
and streptomycin and grown to confluence overnight in 6 well trays. HeLa cells were washed 166 
twice with Dulbecco's PBS (D-PBS) and once in DMEM prior to inoculation with mid 167 
exponential-phase bacteria diluted in DMEM. At 90 min post-infection the inoculum was 168 
aspirated and an overlay (DMEM, 5% FCS, 20 µg gentamicin ml-1, 0.5% agarose [Seakem 169 
ME]) was added to each well. The second overlay (DMEM, 5% FCS, 20 µg gentamicin ml-1, 170 
0.5% agarose, 0.1% Neutral Red solution [Gibco BRL]) was added at either 24 h or 48 h 171 
post-infection and plaque formation observed 6-8 h later. Plaques were in general visible 172 
without staining at 48 h. 173 
Indirect immunofluorescence of whole bacteria. Indirect immunofluorescence labelling of 174 
bacteria was performed as described previously (May & Morona, 2008). Briefly, equivalent 175 
numbers of mid exponential-phase bacteria were fixed in formalin (3.7% (v/v) 176 
paraformaldehyde in 0.85% saline) and either centrifuged onto poly-L-lysine-coated 177 
coverslips for microscopic analysis or kept in suspension for flow cytometric analysis. 178 
Bacteria were incubated with the desired primary antibody diluted 1:100 in PBS with 10% 179 
foetal calf serum (FCS) prior to washing with PBS and labelling with either an Alexa 488-180 
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conjugated donkey anti-rabbit or Alexa 488-conjugated donkey anti-mouse secondary 181 
antibody (Molecular Probes). Microscopy was performed as described previously (May & 182 
Morona, 2008), using an Olympus IX-70 microscope with phase-contrast optics using a 100× 183 
oil immersion objective and a 1.5× enlarger as required. Fluorescence and phase-contrast 184 
images were false colour merged using Metamorph (Version 6.3r7, Molecular devices). 185 
Alternatively, after labeling, cells were washed three times in PBS and then diluted to 186 
5 ml in PBS for analysis by flow cytometry (BD FACSCanto, BD Biosciences, San Jose, CA, 187 
USA). 188 
Infection of tissue culture monolayers with S. flexneri and immunofluorescence 189 
labelling. Infection of HeLa cells and immunofluorescence labelling were performed as 190 
recently described (May & Morona, 2008). Briefly, HeLa cells were inoculated with mid 191 
exponential-phase bacteria and incubated for 1 h. The monolayers were washed, incubated 192 
with media containing gentamicin for a further 1.5 h. The monolayer was washed, formalin-193 
fixed, and permeabilized with 0.1% Triton X-100. After blocking in 10% FCS the infected 194 
cells were incubated with polyclonal anti-Shigella LPS-Oag (Denka Seiken Co., Japan) to 195 
label bacteria. After subsequent washing, cells were incubated with Alexa 594-conjugated 196 
donkey anti-rabbit antibodies (Molecular probes). F-actin was visualised by staining with 197 
FITC phalloidin (0.1 µg ml-1, Sigma).  198 
 199 
RESULTS 200 
In situ chemical cross-linking of IcsA.  In order to determine if IcsA is present within a 201 
protein complex, in situ chemical cross-linking was performed. Mid exponential-phase 202 
cultures of S. flexneri ΔicsA [pIcsA] (RMA2090, Table 1) were treated with membrane-203 
permeable cross-linking agents dithio-bis(succinimidylpropionate) (DSP), and whole-cell 204 
lysates were subjected to SDS-PAGE and Western blotting with an anti-IcsA antibody. We 205 
reproducibly detected the presence of a high molecular weight (HMW) complex following 206 
cross-linking (Fig. 1, lane 2). This complex had an apparent molecular mass greater than 460 207 
kDa, as determined by comparison to HighMark protein standard (Invitrogen). Formation of 208 
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this HMW product was reversed by the addition of β-mercaptoethanol, which can cleave the 209 
disulphide bond in the spacer arm of DSP to allow separation of the cross-linked products 210 
(Fig. 1, lane 1). This HMW complex could also be detected following cross-linking with 211 
formaldehyde (Fig S1 in the supplemental material). 212 
Oligomerization of the N. gonorrhea IgA protease and E. coli AIDA has been 213 
suggested to be mediated through interaction of individual translocation domains (Müller et 214 
al., 2005; Veiga et al., 2002). We examined previously characterized IcsA effector domain 215 
deletion mutants (Suzuki et al., 1996) for formation of HMW complexes. DSP crosslinking 216 
of IcsAΔ508-730 (RMA2208) or IcsAΔ103-507 (RMA2209) produced HMW products, 217 
comparable to IcsAWT (RMA2205) (Fig. 1, lanes 3-6). These data indicated that no individual 218 
region within IcsA103-730 is alone responsible for formation of the HMW complex; we cannot 219 
exclude that multiple interactions within this region are involved. Alternately, the data 220 
indicate that IcsA HMW complex formation may be mediated by a region outside of the 221 
studied deletions, namely by the translocation domain (IcsA758-1102). 222 
Lipopolysaccharide (LPS) is a major constituent of the OM of Gram-negative bacteria 223 
consisting of three major parts - the lipid A, the core polysaccharide, and the O antigen (Oag) 224 
polysaccharide chain. The Oag component of LPS has been shown to influence both IcsA 225 
function and surface localization, restricting the protein to the cell pole (Hong & Payne, 226 
1997; Morona & Van Den Bosch, 2003a, b; Sandlin et al., 1994). Rough LPS (R-LPS) 227 
lacking the Oag component, was reported to allow IcsA diffusion away from the cell pole 228 
(Robbins et al., 2001). We hypothesized that cross-linking of IcsA into a HMW product may 229 
be dependent on the spatial confinement of IcsA proteins to the pole or be facilitated by 230 
lateral LPS-IcsA interactions. Hence, we examined the IcsA complex formation in the 231 
absence of LPS-Oag. HMW IcsA-related complexes were observed following DSP cross-232 
linked of IcsA expressed in the rough LPS strain S. flexneri ΔicsA ΔrmlD [pIcsA] 233 




Co-immunoprecipitation of epitope-tagged IcsA proteins. Chemical cross-linking had 236 
indicated the presence of IcsA within a HMW complex and we were particularly interested in 237 
determining if IcsA is able to self-associate. We applied reciprocal co-purification of 238 
differentially epitope-tagged IcsA proteins to determine whether IcsA-IcsA interactions were 239 
taking place within this putative complex. 240 
Sites permissive for epitope insertion within the IcsA passenger domain had been 241 
previously identified (May & Morona, 2008). The IcsAi87 protein has a 5 amino acid linker-242 
insertion at amino acid 87 and when expressed in S. flexneri, was found to be comparable to 243 
wild-type (IcsAWT) with respect to: (i) levels of production; (ii) polar localization at the 244 
bacterial surface; and (iii) function, determined by assaying plaque formation on HeLa cell 245 
monolayers as a measure of intercellular spreading ability (May & Morona, 2008). 246 
Consequently, icsAi87 was chosen for epitope tagging by exploiting a unique NotI restriction 247 
site within the linker. Either a synthetic FLAG epitope (DYKDDDDK), or BIO epitope 248 
(GLNDIFEAQKIEWH; a substrate for metabolic biotinylation by the BirA biotin-protein 249 
ligase; (Cull & Schatz, 1999), were introduced into icsAi87 as described in the Methods. 250 
E. coli UT5600 strains expressing both epitope-tagged IcsA proteins together 251 
(IcsAi87::FLAG and IcsAi87::BIO; MG157, Table 1), or tagged proteins individually with control 252 
IcsAWT, were generated (MG250 and MG251, Table 1). Overexpression of BirA increased the 253 
levels of biotinylated IcsAi87::BIO, while retaining the high specificity of the biotinylation 254 
reaction (data not shown). Hence, all co-expression strains additionally carried plasmid 255 
pCY216 that expressed the birA enzyme (Chapman-Smith et al., 1994). Insertion of neither 256 
the FLAG nor the BIO epitope affected the function of IcsAi87 (data not shown). 257 
The OM fractions of the co-expression strains were isolated and purification strategies 258 
directed against either epitope were performed independently: FLAG M2 resin was used for 259 
purification of IcsAi87::FLAG; and streptavidin-Dynabeads were used for purification of 260 
biotinyl-IcsAi87::BIO. Co-purification of tagged IcsA proteins was assessed by Western 261 
blotting using either an antibody conjugate (FLAG epitope) or streptavidin conjugates 262 
(biotin-modified BIO epitope) in each of the eluents. Following purification of IcsAi87::FLAG 263 
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with FLAG M2 resin from OMs of strain MG157, biotinyl-IcsAi87::BIO was found to co-purify 264 
with it (Fig. 2a, lane 2). Taking into consideration that any IcsAi87::BIO that remained 265 
unbiotinylated could not be detected with streptavidin, our data suggests the amount of co-266 
purified biotinyl-IcsAi87::BIO we observed was significant. Under the same conditions, when 267 
OMs of strain MG251 that expressed IcsAWT were used, biotinyl-IcsAi87::BIO was not detected 268 
in the eluted sample (Fig. 2a, lane 1) showing that the FLAG M2 resin was specific for the 269 
FLAG epitope. Similarly, when biotinyl-IcsAi87::BIO was purified from OMs of strain MG157 270 
using streptavidin-Dynabeads, IcsAi87::FLAG was found to co-purify with it (Fig. 2b, lane 2). 271 
However, under the same conditions, IcsAi87::FLAG did not purify from OMs of strain MG250 272 
that co-expressed the untagged control protein IcsAWT (Fig. 2b, lane 3), showing that the 273 
streptavidin-Dynabeads were specific for the biotin-modified BIO epitope. Based on these 274 
results we conclude that the IcsA self-association occurs in the OM and this self-association 275 
is resistant to disruption by the detergent Zwittergent 3-14. 276 
 277 
Identification of negative-dominant IcsAi mutants. Having detected the existence of IcsA- 278 
IcsA interactions by co-purification, we investigated if IcsA self-association impacted on its 279 
function in intracellular motility. We hypothesized the existence of IcsA mutations that 280 
would exert negative dominance on IcsA function in ABM and intercellular spread when co-281 
expressed with IcsAWT. A collection of IcsAi insertion mutants has been previously identified 282 
(May & Morona, 2008) and some of these were screened for negative dominance in 283 
intercellular spreading when co-expressed with IcsAWT in a S. flexneri KMRM254 284 
background (data not shown). Two mutants (IcsAi563, and IcsAi677) exerted a clear negative 285 
dominant phenotype when expressed with either IcsAWT (Fig. 3a) or the functionally 286 
equivalent IcsAi87::FLAG (Fig. S2). Individually, IcsAi563 and IcsAi677 are unable to recruit N-287 
WASP (Fig. S3) or efficiently generate F-actin tails and promote plaque formation on HeLa 288 
cell monolayers (May & Morona, 2008). When either mutant was co-expressed with IcsAWT, 289 
F-actin tails could still detected by FITC-phalloidin staining of fixed monolayers infected 290 
with the various Shigella strains (Fig. 3b). However, efficient F-actin tail formation is 291 
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required for efficient intercellular spreading. As a sensitive measure of the proficiency of the 292 
detected F-actin tails to drive intercellular spreading, the ability of the co-expression strains 293 
to form plaques on HeLa cell monolayers was assessed. Plaque formation could not be 294 
detected when IcsAi563 was co-expressed with IcsAWT and co-expression of IcsAi677 with 295 
IcsAWT resulted in only a few small plaques (<1 mm diameter) that were markedly smaller 296 
than those formed by the control strain KMRM255 (which typically formed between 50-100 297 
plaques/well, averaging 6.4 mm in diameter) (Fig. 3a). The defective plaque formation 298 
clearly indicated that the F-actin tails formed by these strains were not comparable to wild-299 
type, as they were not able to facilitate efficient ABM and intercellular spreading. 300 
 301 
Negative dominance of IcsAi mutants on IcsAWT does not arise due to defects in 302 
production, export or polar localization of the wild-type protein. The observation of 303 
negative dominance when IcsAWT was expressed with IcsAi mutants could have arisen by 304 
titration by the mutant proteins of factors required for IcsA synthesis, polar localisation and 305 
surface presentation, resulting in a decrease-in-function of IcsAWT. We sought to scrutinise 306 
these possibilities by using a tagged version of IcsAWT (IcsAi87::FLAG) in S. flexneri ΔicsA 307 
strains additionally expressing IcsAi563 or IcsAi677 mutants. IcsAi87::FLAG retains wild-type 308 
equivalent function in plaque formation (Fig. S2 in the supplemental material). We confirmed 309 
that the IcsAi563 and IcsAi677 mutants had a negative dominant effect on IcsAi87::FLAG with 310 
respect to plaque formation (Fig. S2). 311 
The levels of IcsAi87::FLAG protein during co-expression with IcsAi563 and IcsAi677, 312 
were then assessed by Western blotting with anti-FLAG M2 antibodies. IcsAi87::FLAG 313 
production was equivalent when expressed alone from either plasmid pKMRM250 (pBR233-314 
derivative) or plasmid pKMRM270 (pBBR1MCS2-derivative), confirming the suitability of 315 
the plasmids for use in co-expression studies (not shown). Production of IcsAi87::FLAG when 316 
co-expressed with IcsAWT in KMRM275 was comparable to production of IcsAi87::FLAG when 317 
expressed alone in KMRM273 (Table 1; Fig. 4a). Despite being unable to form detectable 318 
plaques, the strain co-expressing IcsAi677 with IcsAi87::FLAG expressed comparable levels of 319 
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FLAG-tagged functional IcsA; co-expression of IcsAi563 and IcsAi87::FLAG resulted in a slight 320 
decrease in FLAG-tagged IcsA (Fig. 4a). Additionally, we quantitated the level of surface 321 
exposed IcsAi87::FLAG by flow cytometry. Co-expression of IcsAi87::FLAG with either mutant did 322 
not result in a detectable reduction in the amount of functional protein at the bacterial surface 323 
(Fig. 4b). Moreover, the surface distribution of IcsAi87::FLAG was seen by immunofluorescence 324 
to be polar when co-expressed either with IcsAWT, IcsAi563, or IcsAi677 (Fig. 4c). 325 
Taken together, these data suggest that the negative dominant phenotype conferred by 326 
IcsAi563 and IcsAi677 during co-expression with active IcsA results from a net functional 327 
defect at the cell surface, and was not due to these mutants affecting the expression, export or 328 
localisation of functional IcsA proteins.  329 
 330 
DISCUSSION  331 
Subversion of the host cell actin regulatory network enables Shigellae infection to spread 332 
throughout the human intestinal epithelium. IcsA is both necessary and sufficient to 333 
potentiate actin-based motility through activation of N-WASP. The nature of IcsA interaction 334 
with N-WASP remains poorly understood. In light of data demonstrating that the 335 
conventional AT, IgA protease from N.gonorrhoea, forms an oligomer in the OM, we sought 336 
to characterize the properties of IcsA in the OM. In this study, we tested the hypothesis that 337 
IcsA is able to self-associate.  338 
 The self-association of IcsA was supported by the presence of HMW IcsA-related 339 
complexes that were detected following cross-linking of whole cells with DSP or 340 
formaldehyde. While IgA1 protease in vitro oligomerization was reported as homo-341 
pentameric (Veiga et al., 2002), our findings do not exclude the possibility that IcsA 342 
oligomerization is hetero-oligomeric. The reciprocal co-purification and genetic interaction 343 
data we have presented in this study strongly suggests the existence of IcsA-IcsA interactions 344 
within the HMW oligomer. 345 
Support for the existence of direct IcsA-IcsA interactions within HMW complexes 346 
was provided by observation of negative dominant genetic interactions of IcsAi linker-347 
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insertion mutants (IcsAi563 and IcsAi677) on IcsA function in intercellular spreading (assessed 348 
with both IcsAWT and IcsAi87::FLAG). One of two explanations can account for negative 349 
dominant phenotypes (Herskowitz, 1987). The first is titration of factors away from the 350 
functional IcsA protein by co-expression of a mutants IcsAi protein. Since no defects were 351 
observed in functional IcsA whole-cell protein levels, in cell surface expression, or in polar 352 
targeting, the factors that underpin the respective processes were not titrated by IcsAi 353 
mutants. Similarly, the examined IcsAi mutants cannot recruit N-WASP (May & Morona, 354 
2008), and titration of this host cell ligand from functional IcsA was improbable. These 355 
findings indicated that titration could not explain the negative dominant phenotype. Instead, 356 
we favour the alternate explanation of negative dominance: that the products of the functional 357 
icsA and mutant icsAi alleles functionally interact in vivo. We suggest that during co-358 
expression, IcsAi mutants are included into mixed complexes with functional IcsA proteins. 359 
The inclusion of IcsAi proteins renders these complexes defective for efficient F-actin tail 360 
formation, as evidenced by defective intercellular spreading. This deficiency in the negative 361 
dominant co-expression strains occurs despite levels of functional IcsA that, when expressed 362 
alone, can efficiently potentiate intercellular spreading. Clearly, IcsA-IcsA interactions are 363 
functionally important. 364 
 We have demonstrated for the first time biochemical and genetic evidence of IcsA 365 
self-association. Furthermore, the observed negative dominance of certain inactive IcsAi 366 
mutant proteins is consistent with self-association being important for the biological function 367 
of the protein. Although N-WASP and WASP family members are activated by an array of 368 
different molecules, these activators act by allosteric relief of N-WASP/WASP auto-369 
inhibition (Kim et al., 2000), and by facilitating clustering and multimerization of active N-370 
WASP (Padrick et al., 2008; Padrick & Rosen, 2010), often by their own oligomerization. 371 
Therefore, we hypothesise the self-association of IcsA may play a role in N-WASP 372 
clustering. In our study the incorporation of defective IcsAi563 or IcsAi677 proteins into 373 
IcsAWT-containing complexes could interfere with efficient spatial clustering of activated N-374 
WASP, thereby accounting for the reduced efficiency of intercellular spreading. In this way, 375 
15 
 
IcsA would appear analogous to other bacterial and host proteins that either interact with or 376 
functionally mimic WASP family members. Most of these have been shown to either directly 377 
self-associate (Enterohaemorrhagic Escherichia coli intimin-tir), to spatially cluster (Listeria 378 
monocytogenes ActA) or are inherently multivalent with internal repeats 379 
(Enterohaemorrhagic Escherichia coli EspF, EspFU and Tccp) (Alto et al., 2007; Campellone 380 
et al., 2008; Footer et al., 2008; Sallee et al., 2008; Touzé et al., 2004). Significantly, our 381 
data demonstrates self-association of yet another protein known to activate a WASP family 382 
protein, which has emerged as an important feature in the regulation of the host actin-383 
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TABLE 1. Bacterial strains and plasmids used 566 
 567 
Strain/Plasmid Relevant characteristics * Reference/source 
E. coli K-12   
DH5α 
endA hsdR supE44 thi-1 recA1 gyrA relAΔ 




F- ara-14 leuB6 secA6 lacY1 proC14 tsx-67 
Δ(ompT-fepC)266 entA403 trpE38 rfbD1 
rpsL109 xyl-5 mtl-1 thi-1  
Laboratory collection 
MG157 UT5600 [pKMRM270, pMG55, pCY216] This study 
MG250 UT5600 [pKMRM270, pKMRM1, pCY216] This study 
MG251 UT5600 [pKMRM252, pMG55, pCY216] This study 
   
S. flexneri   
2457T S. flexneri 2a wild-type Laboratory collection 
RMA2041 2457T ΔicsA::TcR (Van Den Bosch & Morona, 2003) 
RMA2090 RMA2041 [pIcsA] (Van Den Bosch & Morona, 2003)  
RMA2107 RMA2041 ΔrmlD::KmR [pIcsA] (Van Den Bosch & Morona, 2003) 
RMA2205 RMA2041 [pD10-1] This study 
RMA2208 RMA2041 [pD10-1 virG3] This study 
RMA2209 RMA2041 [pD10-1 virG4] This study 
KMRM111 RMA2041 [pKMRM11] (May & Morona, 2008) 
KMRM134 RMA2041 [pKMRM34] (May & Morona, 2008) 
KMRM254 RMA2041 [pKMRM252] This study 
KMRM255 RMA2041 [pKMRM252] [pIcsA] This study 
KMRM256 RMA2041 [pKMRM252] [pKMRM11] This study 
KMRM258 RMA2041 [pKMRM252] [pKMRM34] This study 
KMRM273 RMA2041 [pKMRM270] This study 
KMRM275 RMA2090 [pKMRM270] This study 
KMRM276 RMA2041 [pKMRM11] [pKMRM270] This study 
KMRM277 RMA2041 [pKMRM34] [pKMRM270] This study 
   
Plasmids   
pBBR1MCS-2 Broad-host-range vector; Km
R; medium copy 
no.; ori compatible with ColE1 plasmids (Kovach et al., 1995) 
pCY216 encodes BirA; CmR (Chapman-Smith et al., 1994) 
pD10-1 encodes VirG (same as IcsAWT); TpR (Suzuki et al., 1996) 
pD10-1virG3 encodes VirGΔ508-730; TpR  (Suzuki et al., 1996) 
pD10-1virG4 encodes VirGΔ103-507; TpR (Suzuki et al., 1996) 
pIcsA icsA gene cloned into pBR322; ApR (Van Den Bosch & Morona, 2003)  
pKMRM1 pBR322 encoding IcsAi87; ApR (May & Morona, 2008) 




pKMRM34 pBR322 encoding IcsAi677; ApR (May & Morona, 
2008) 
pKMRM250 pBR322 encoding IcsAi87::FLAG; ApR This study 
pKMRM252 pBBR1MCS-2 encoding IcsAWT; KmR This study 
pKMRM270 pBBR1MCS-2 encoding IcsAi87::FLAG; KmR This study 
pMG55 pBR322 encoding IcsAi87::BIO; ApR This study 
* CmR, chloramphenicol-resistant; TcR, tetracyline-resistant; KmR, kanamycin-resistant; ApR, ampicillin-568 
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FIG. 1. DSP cross-linking of S. flexneri. Mid-exponential phase cultures of indicated S. 
flexneri strains were treated with 0.2 mM DSP as described in the Methods. Whole 
membranes were isolated and resuspended in sample buffer with or without β-
mercaptoethanol (β-ME) and heated to 60°C. Cross-linked samples were resolved by SDS 
PAGE (7.5% polyacrylamide) and analysed by Western blotting with anti-IcsA antibody. 
Sizes were approximated from the electrophoretic mobility of HighMark (Invitrogen) protein 
standard. Expected electrophoretic migration of monomeric IcsA truncation mutants is 
indicated. IcsA* indicates HMW complexes containing IcsA. The resolving gel is shown. 
 
FIG. 2. Co-purification analysis. E. coli K-12 strains (MG157, MG250, MG251) were 
grown, then Zwittergent 3-14-solubilised OM fractions were prepared and purified through 
FLAG-agarose resin (a) or streptavidin-Dynabeads (b), as described in the Methods.  
Samples were subjected to SDS-PAGE, and Western blotting with either a rabbit anti-FLAG 
M2 antibody followed with an anti-rabbit Ig HRP conjugate, or streptavidin-HRP, as 
indicated. 
 
FIG. 3. Plaque and F-actin tail formation by complemented strains. (a) Relative size and 
frequency of plaque formation on HeLa cell monolayers by S. flexneri strains expressing 
either IcsAWT (RMA2090), or IcsAi563 (KMRM111), or IcsAi677 (KMRM134) alone, and S. 
flexneri co-expressing IcsAWT with IcsAi563 (KMRM256), IcsAi677 (KMRM258), or IcsAWT 
control (KMRM255). Plaque assay was performed as described in detail in the materials and 
methods. (b) IF microscopy of F-actin tail formation by intracellular S. flexneri strains 
expressing either IcsAWT (RMA2090), or IcsAi563 (KMRM111), or IcsAi677 (KMRM134) 
alone, and S. flexneri co-expressing IcsAWT with IcsAi563 (KMRM256), IcsAi677 
(KMRM258), or IcsAWT control (KMRM255). HeLa cells infected with S. flexneri were 
labelled with anti-LPS antibodies and Alexa 594-conjugated donkey anti-rabbit antibodies, 
and F-actin was labelled with FITC phalloidin as described in detail in the Methods. Strains 





FIG. 4. Protein levels and distribution of IcsAi87::FLAG during co-expression with IcsAi563 
and IcsAi677 mutants. (A) Whole-cell lysates from mid exponential-phase cultures of 
indicated S. flexneri strains expressing IcsAi87::FLAG with IcsAi563 (KMRM276), IcsAi677 
(KMRM277), or control IcsAWT (KMRM275) were subjected to Western blotting with anti-
FLAG antibodies. The samples represent 1×10
8
 cells. IcsA’i87::FLAG is a proteolytic fragment 
also observed in IcsAWT. (B) FACS analysis of the indicated S. flexneri strains. Equivalent 
numbers of bacteria were labelled with rabbit anti-FLAG and then anti-rabbit-Alexa 488 
antibodies, and fluorescence intensity assessed by flow cytometry as described in the 
Material and Methods. Grey area denotes fluorescence intensities of the negative control 
strain (KMRM250). For all strains, n = 50,000 cells. (C) IF microscopy of IcsAi87::FLAG 
surface distribution. Mid exponential-phase cultures of indicated S. flexneri strains were 
formalin fixed and labelled with anti-FLAG antibodies and then goat anti-rabbit Alexa 488 
secondary antibodies. Scale bar = 3 µm. 
 
FIG. 1. DSP cross-linking of S. flexneri. Mid-exponential phase cultures of indicated 
S. flexneri strains were treated with 0.2 mM DSP as described in the Methods. Whole 
membranes were isolated and resuspended in sample buffer with or without β-
mercaptoethanol (β-ME) and heated to 60°C. Cross-linked samples were resolved by 
SDS PAGE (7.5% polyacrylamide) and analysed by Western blotting with anti-IcsA 
antibody. Sizes were approximated from the electrophoretic mobility of HighMark 
(Invitrogen) protein standard. Expected electrophoretic migration of monomeric IcsA 
truncation mutants is indicated. IcsA* indicates HMW complexes containing IcsA. 
The resolving gel is shown. 
• • • 














1 2 3 (a) 
(b) 
FIG. 2. Co-purification analysis. E. coli K-12 strains (MG157, MG250, MG251) 
were grown, then Zwittergent 3-14-solubilised OM fractions were prepared and 
purified through FLAG-agarose resin (a) or streptavidin-Dynabeads (b), as described 
in the Methods.  Samples were subjected to SDS-PAGE, and Western blotting with 
either a rabbit anti-FLAG M2 antibody followed with an anti-rabbit Ig HRP 
conjugate, or streptavidin-HRP, as indicated. 
 
  
FIG. 3. Plaque and F-actin tail formation by complemented strains. (a) 
Relative size and frequency of plaque formation on HeLa cell monolayers 
by S. flexneri strains expressing either IcsAWT (RMA2090), or IcsAi563 
(KMRM111), or IcsAi677 (KMRM134) alone, and S. flexneri co-expressing 
IcsAWT with IcsAi563 (KMRM256), IcsAi677 (KMRM258), or IcsAWT control 
(KMRM255). Plaque assay was performed as described in detail in the 
materials and methods. (b) IF microscopy of F-actin tail formation by 
intracellular S. flexneri strains expressing either IcsAWT (RMA2090), or 
IcsAi563 (KMRM111), or IcsAi677 (KMRM134) alone, and S. flexneri co-
expressing IcsAWT with IcsAi563 (KMRM256), IcsAi677 (KMRM258), or 
IcsAWT control (KMRM255). HeLa cells infected with S. flexneri were 
labelled with anti-LPS antibodies and Alexa 594-conjugated donkey anti-
rabbit antibodies, and F-actin was labelled with FITC phalloidin as 
described in detail in the Methods. Strains were assessed in three 
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FIG. 4. Protein levels and distribution of IcsAi87::FLAG during co-expression with 
IcsAi563 and IcsAi677 mutants. (A) Whole-cell lysates from mid exponential-phase 
cultures of indicated S. flexneri strains expressing IcsAi87::FLAG with IcsAi563 
(KMRM276), IcsAi677 (KMRM277), or control IcsAWT (KMRM275) were subjected 
to Western blotting with anti-FLAG antibodies. The samples represent 1×108 cells. 
IcsA’i87::FLAG is a proteolytic fragment also observed in IcsAWT. (B) FACS analysis of 
the indicated S. flexneri strains. Equivalent numbers of bacteria were labelled with 
rabbit anti-FLAG and then anti-rabbit-Alexa 488 antibodies, and fluorescence 
intensity assessed by flow cytometry as described in the Material and Methods. Grey 
area denotes fluorescence intensities of the negative control strain (KMRM250). For 
all strains, n = 50,000 cells. (C) IF microscopy of IcsAi87::FLAG surface distribution. 
Mid exponential-phase cultures of indicated S. flexneri strains were formalin fixed 
and labelled with anti-FLAG antibodies and then goat anti-rabbit Alexa 488 
secondary antibodies. Scale bar = 3 µm. 
  
 
